|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash Flows from Operating Activities | |||
| Net Income | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization of fixed assets | |||
| Amortization of other intangible assets | |||
| Amortization on assumed liabilities | |||
| Accretion income related to acquired loans | |||
| Amortization of housing tax credits | |||
| Realized (gain) loss on sales of available-for-sale securities | |||
| Realized (gain) on sales of OREO property | |||
| Write-down on OREO property | |||
| Provision for (recapture of) credit losses | |||
| Income from company-owned life insurance | |||
| Deferred tax expense (benefit) | |||
| (Gain) loss on disposal of fixed assets | |||
| Accretion of securities | |||
| Amortization of securities | |||
| Share-based compensation expense | |||
| Repayment of operating lease liabilities | |||
| (Gain) on loans held-for-sale | |||
| Proceeds from sales of loans held-for-sale | |||
| Change in fair value of loans held-for-sale | |||
| Originations of loans held-for-sale | |||
| (Increase) decrease in accrued interest receivable | |||
| (Increase) decrease in other assets | |||
| Increase in accrued interest payable and other liabilities | |||
| Net cash flows provided by operating activities | |||
| Cash Flows from Investing Activities | |||
| Proceeds from maturities, prepayments, and calls of securities available-for-sale, net | |||
| Proceeds from sales of securities available-for-sale, net | |||
| Purchases of securities available-for-sale, net | |||
| Net cash from merger | |||
| Sales of restricted stock | |||
| Purchases of restricted stock | |||
| Proceeds from sales of OREO properties | |||
| Proceeds from sales of property and equipment | |||
| Purchases of property and equipment, net of disposals | |||
| Proceeds from company-owned life insurance | |||
| (Purchases) proceeds from company-owned life insurance | |||
| (Increase) decrease in loans made to customers, net | |||
| Net cash flows provided by (used in) investing activities | |||
| Cash Flows from Financing Activities | |||
| Net increase (decrease) in non-interest-bearing accounts | |||
| Net increase (decrease) in interest-bearing accounts | |||
| Increase (decrease) in other short-term borrowings | |||
| Repayment of subordinated debt | |||
| Repayment of finance lease liabilities | |||
| Proceeds from employee stock purchase program | |||
| Cash dividends paid | |||
| Issuance of common stock | |||
| Treasury stock transactions | |||
| Net cash flows provided by (used in) financing activities | |||
| (Decrease) increase in cash and cash equivalents | |||
| Cash and cash equivalents | |||
| Beginning of year | |||
| End of year | |||
| Supplemental Disclosures of Cash Flow Information | |||
| Cash payments for: | |||
| Interest paid to depositors | |||
| Interest paid on other borrowed funds | |||
| Interest paid on short-term borrowings | |||
| Interest paid on subordinated debt and trust preferred securities | |||
| Interest paid on finance lease | |||
| Income taxes | |||
| Income taxes paid (net of refunds) | |||
| Federal | |||
| State | |||
| West Virginia | |||
| Maryland | |||
| New York | |||
| District of Columbia | |||
| Other | |||
| Change in unrealized gains on available-for-sale securities | |||
| Change in pension plan benefits | |||
| Transfers to OREO | |||
| Lease liability arising from obtaining right-of-use assets | |||
| Premises & equipment transferred to property held-for-sale | |||
| Transfers from portfolio loans to loans held-for-sale | |||
| Financing of sale from loans held-for-sale | |||
| Common stock issued for merger, net | |||
| Preferred stock issued for merger, net | |||
| Fair value of assets purchased in merger | |||
| Fair value of liabilities assumed in merger |
Loading...